Bmp Signaling Regulates Hand1: History
View Latest Version
Please note this is an old version of this entry, which may differ significantly from the current revision.
Subjects: Cardiac & Cardiovascular Systems
Contributor:
Mingjie Zheng

The bone morphogenetic protein (Bmp) signaling pathway and the basic helix–loop–helix (bHLH) transcription factor Hand1 are known key regulators of cardiac development. In this study, we investigated the Bmp signaling regulation of Hand1 during cardiac outflow tract (OFT) development. In Bmp2 and Bmp4loss-of-function embryos with varying levels of Bmp in the heart, Hand1 is sensitively decreased in response to the dose of Bmp expression. In contrast, Hand1 in the heart is dramatically increased in Bmp4 gain-of-function embryos. We further identified and characterized the Bmp/Smad regulatory elements in Hand1. Combined transfection assays and chromatin immunoprecipitation (ChIP) experiments indicated that Hand1 is directly activated and bound by Smads. In addition, we found that upon the treatment of Bmp2 and Bmp4, P19 cells induced Hand1 expression and favored cardiac differentiation. Together, our data indicated that the Bmp signaling pathway directly regulates Hand1 expression in a dose-dependent manner during heart development.

  • Bmp signaling
  • Hand1
  • Smad
  • transcriptional regulation
  • heart development
  • cardiomyocyte differentiation

1. Introduction

Congenital heart defects (CHDs) are the most common birth defects, with an estimated prevalence of 1% in newborns [1]. Cardiac outflow tract (OFT) defects are the most common CHDs and account for one-third of all reported CHDs in human births. The development of the OFT involves interactions and coordination between two types of progenitor pools: second heart field (SHF) progenitors and cardiac neural crest cells (NCCs), regulated by a complex, fine-tuned molecular regulatory network [2][3].
Bone morphogenetic proteins (Bmps) [4] are a family of growth factors belonging to the transforming growth factor beta (TGF-β) superfamily [5]. In the canonical Bmp pathway, Bmp ligands such as Bmp2 and Bmp4 bind to their dual-specificity kinase and heterodimeric receptor complex, consisting of type I and type II receptors, which phosphorylates downstream receptor-regulated Smads (R-Smads), i.e., Smad1, Smad5, and Smad8 (Smad1/5/8) [6][7]. The phospho-R-Smads then form an oligomeric complex with Smad4 and translocate into the nucleus to regulate the expression of downstream genes. The Smad complex can act as both a transcriptional activator and a repressor to regulate target gene expression. The highly conserved Bmp signaling pathway is essential for heart development [8][9], including OFT formation [10][11][12]. Mouse models with Bmp signaling disruptions result in embryonic lethality and CHDs [13][14][15][16][17], as evidenced by Bmp2/4 deletions in the SHF resulting in lethality by embryonic day (E) 12.5 with deficient OFT myocardial differentiation in mice [17].
The hand (the heart- and neural crest derivatives-expressed protein 1) proteins are a subclass of basic helix–loop–helix (bHLH) transcription factors (TFs) that can form homo- and heterodimer combinations with multiple bHLH partners, mediating transcriptional activity in the nucleus [18][19]. Previous studies have shown that Hand1 and Hand2 are core TFs that are expressed in the precardiogenic mesoderm to govern essential gene regulatory networks for cardiovascular growth and morphogenesis [20][21][22][23][24]. Hand1 plays a vital role in the specification and/or differentiation of extraembryonic structures such as the yolk sac, placenta, and cells of the trophoblast lineages, including cardiac muscle the heart, gut, and sympathetic neuronal development, while also aiding in the proper development of tissues populated by Hand1-expressing NCCs [25][26]. Hand1 deletion in mice results in lethality at E8-8.5, with perturbed heart development at the looping stage [20][27]. Several cardiac studies demonstrated that Hand1 is an important regulator for cardiac precursor cell fate decision and cardiac morphogenesis [20][21][28][29]. Moreover, mutated HAND1 has been shown to hinder the effect of GATA4, and is associated with congenital heart disease in human patients [30][31]. Mice lacking Hand2 are embryonically lethal at E10.5, persisting with right ventricular hypoplasia and vascular malformations [22][32]. HAND2 loss-of-function mutation was found to contribute to human CHDs, and enhanced susceptibility to familial ventricular septal defect (VSD) and double outlet right ventricle (DORV) [33].
In this study, we combined both in vivo mouse genetics and in vitro molecular analyses to investigate the regulation of Hand1 by Bmp signaling. We found that canonical Bmp-Smad signaling regulates the expression of Hand1 in a dosage-dependent manner during embryonic heart development, and functions through both cell-autonomous and non-cell-autonomous regulation. Our results suggested that Smads directly bind to the 5′UTR of Hand1 and activate its expression. In addition, we found that Bmp treatment can activate Hand1 expression and promote the expression of cardiac TFs such as Nkx2.5 and Gata4 in P19 cells. Taken together, our data uncovered a fine-tuned canonical Bmp signaling-Hand1 regulation during heart development.

2. Results

2.1. Hand1 Expression Decreases in a Dose-Sensitive Manner in Response to Bmp2 and Bmp4 Deficiency during Heart Development

SHF progenitors contribute greatly in the formation of the OFT, inflow tract and right ventricle (RV) [34]. To determine Hand1 expression changes in response to Bmp loss-of-function during embryonic OFT development, we generated compound Bmp2 and Bmp4 double-conditional knockout (Bmp2/4 dCKO) mutants by crossing the SHF-specific Mef2ccre driver with the Bmp2 and Bmp4 conditional null alleles. Through this cross, we obtained Bmp2/4 dCKO mutants and Bmp compound mutants with varying levels of Bmp deficiency, including Bmp2 homozygous, Bmp4 heterozygous mutants (Bmp2−/−; Bmp4+/−) and Bmp4 homozygous, Bmp2 heterozygous mutants (Bmp2+/−; Bmp4−/−). Whole-mount in situ hybridization indicated that compared to the control embryos (Figure 1A), both Bmp2−/−; Bmp4+/− (Figure 1B) and Bmp2+/−; Bmp4−/− (Figure 1C) mutant embryos had a dramatic decrease in Hand1 expression in the OFT. Strikingly, Bmp2/4 dCKO mutants (Figure 1D) presented with fully abolished Hand1 expression in the OFT; however, in all Bmp mutant samples (compound and dCKO mutants), Hand1 was still highly expressed in the non-SHF-derived structures such as the left ventricle (LV). These findings indicate that Hand1 expression is highly sensitive to a Bmp dose-dependent regulation. Histological section analysis of in situ hybridization further confirmed that Hand1 expression was fully abolished in the OFT of Bmp2/4 dCKO mutant hearts (Figure 1F), as compared to the control hearts with a high expression of Hand1 in the OFT (Figure 1E). The qRT-PCR analysis further indicated that Hand1 expression in the hearts of Bmp2/4 dCKO mutants was significantly reduced to around 30% of that of the control hearts at E9.5 (Figure 1G).
Ijms 22 09835 g001 550
Figure 1. Hand1 expression is regulated by Bmp signaling in a dose-dependent manner during mouse heart development. (A–D) Whole-mount in situ hybridization showing Hand1 expression in mouse embryos at E9.5. (E,F) E9.5 sagittal sections showed Hand1 in situ hybridization in the branchial arch and OFT. (G) qRT-PCR analysis of Hand1 expression in control and Bmp2/4 CKO embryos. All genotypes are shown as labeled. B2−/−; B4+/−: Bmp2 homozygous, Bmp4 heterozygous mutants; B2+/−; B4−/−: Bmp4 homozygous, Bmp2 heterozygous mutants; B2−/−; B4-/−: Bmp2/4 dCKO. e, eye; ba, branchial arch; oft, outflow tract. Arrows and arrow heads point out in situ hybridization signals in OFT and SHF. Data are presented as means ± s.e.m. * indicates p-value < 0.05.
During early cardiac development, proliferating SHF progenitor cells add to the OFT and inflow tract, leading to heart tube elongation and its subsequent asymmetric looping formation by E9.5. The other major progenitor cell population contributing to OFT formation is the cardiac NCCs, a highly migratory, multipotent cell population originating from the cranial/vagal region of the dorsal neural tube that subsequently migrates to the OFT. During cardiac morphogenesis, SHF progenitor cells and cardiac NCCs closely interact with each other and coordinately regulate OFT formation [35]. We evaluated expression of the SHF marker Hand2 and the NCC marker Ap2 using whole-mount in situ hybridization, and found that the Bmp2/4 dCKO mutant heart had Hand2 (Figure S1B) and Ap2 (Figure S1D) expression comparable to that of the control embryo (Figure S1A,C). These findings suggest intact SHF and NCC contributions to the OFT, indicating that the abolished Hand1 expression in the OFT of the Bmp2/4 dCKO mutant is not caused by reduced cell populations. Importantly, other than in the SHF-derived OFT, Bmp2/4 deletion in the SHF also caused diminished Hand1 expression in the NCC-derived components of the OFT, suggesting a non-cell-autonomous regulation by Bmp2/4. Together, these data suggested that during development, Bmp signaling regulates Hand1 expression in the SHF- and NCC-derived OFT through cell-autonomous and non-cell-autonomous regulation, in a dose-dependent manner.

2.2. Hand1 is Upregulated in Bmp4 OE Embryos

Finding that Hand1 expression is sensitive to Bmp loss-of-function, we next detected Hand1 expression in the heart with elevated Bmp signaling. Using a conditional Bmp4tetO gain-of-function allele (tetracycline inducible) crossed with the Mef2ccre driver [17][36], we specifically overexpressed Bmp4 in the SHF-derived heart structures (Bmp4 OE). We found that compared with the control heart (Figure 2A), the Bmp4 OE mutant heart had robustly expanded Hand1 expression in the SHF region and SHF-derived structures, including the OFT and RV (Figure 2B), indicated by in situ hybridization staining using a Hand1 probe. The qRT-PCR results further indicated that the elevated Bmp4 expression resulted in a significant increase in Hand1 in the Bmp4 OE mutant heart compared with the control heart at E9.5 (Figure 2C). These results indicated that Bmp signaling activates Hand1 expression during heart development, further supporting the conclusion that Hand1 expression sensitively responds to Bmp signaling dosage.
Ijms 22 09835 g002 550
Figure 2. Hand1 is upregulated upon Bmp4 overexpression (OE). (A,B) Whole-mount in situ hybridization of E9.5 Bmp4 OE embryo compared with control embryo; Bmp4 OE embryos expanded Hand1 expression in the SHF and SHF-derived OFT and RV. (C) qRT-PCR indicated increased Hand1 expression level in Bmp4 OE embryos compared with control embryos. e, eye; ba, branchial arch; oft, outflow tract; rv, right ventricle. Arrows and arrow heads point out in situ hybridization signals in the OFT and SHF. Data are presented as means ± s.e.m. * indicates p-value < 0.05.

2.3. Hand1 Is a Direct Target Activated by the Canonical Bmp/Smad Signaling

Smad TFs function as the major signal transducers for receptors of the Bmp signaling pathway and can interact with specific DNA motifs to regulate gene expression [37][38][39][40]. The R-Smads and Smad4 are composed of two evolutionally conserved domains named Mad Homology 1 and 2 (MH1 and MH2). The MH1 domain is responsible for the Smad binding element’s (SBE) DNA-binding activity, while the MH2 domain is important for heterooligomeric Smad complexes formation and transcriptional activation [41][42]. In addition, based on chromatin immunoprecipitation and structural analysis, Smads have been shown to favor recognizing GC-rich elements (also termed BMP response element (BRE) in certain BMP-responsive genes) [43][44] and CAGAC motifs (also termed Smad binding element (SBE)) [45][46]. To determine if the Bmp/Smad signaling directly regulates Hand1, we undertook sequencing analysis and found that several phylogenetically conserved Smad recognition elements, including the GC-rich elements BRE and SBE, were located in the 5′UTR of Hand1 (Figure 3A and Figure S2).
Ijms 22 09835 g003 550
Figure 3. Hand1 is a direct target activated by the canonical Bmp/Smad signaling. (A) Representative Bmp/Smad regulatory element in Hand1 5′ UTR location (at upper) and sequence alignment (at lower), showing the conservation among mouse and human (source: Ensembl). (B) In Vivo ChIP PCR using E9.5 hearts with indicated antibodies to IP chromatin fragment. PCR band (size: 215bp) contains the Hand1 5′UTR Bmp/Smad regulatory element. (C–F) Hand1 5′UTR reporter luciferase assays: treated with Bmp (C), co-transfected with constitutively active ALK3 (caALK3) (D), pcDNA3.1-Smad6 (E), and pSR siSmad1 (F). Data are presented as means ± s.e.m. * indicates p-value < 0.05.
To determine whether Smads directly bind to Hand1, we performed chromatin immunoprecipitation (ChIP) using a Smad1/5/8 antibody in E9.5 wild-type embryonic heart extracts. There was an obvious enrichment in the anti-Smad1/5/8 immunoprecipitated chromatin compared to the controls, indicating that Smad1/5/8 directly bound to the Hand1 chromatin (Figure 3B). To evaluate whether the potential Bmp/Smad regulatory elements in Hand1 are functional, we made a Hand1 5′UTR (Hand1 reporter) luciferase (Luc) reporter and performed luciferase assays in P19 cells. We found that Bmp treatment resulted in a dramatic and significant induction of Hand1 reporter activity (Figure 3C). Overexpression of the constitutively active Bmpr1a (caALK3) [47] also significantly increased Hand1 reporter activity (Figure 3D). In contrast, overexpression of Smad6, an inhibitory Smad, specifically competed with Smad4 for binding to Smad1 [48], and significantly repressed Hand1 reporter activity (Figure 3E). Hand1 Luc reporter activity was also dramatically decreased when using a knockdown Smad1 short hairpin RNA (shRNA) (Figure 3F). Together, these findings supported the idea that Hand1 is a direct target activated by the canonical Bmp/Smad signaling.

2.4. Bmp Induces Hand1 Expression during Cardiomyogenesis in P19 Cells

Both in vivo and in vitro studies have established the essential roles of Bmp signals in promoting cardiomyocyte differentiation [49][50][51]. P19 cells are undifferentiated stem cells derived from murine teratocarcinoma [52], which can differentiate into multiple cell types [53][54][55]. Previous studies have indicated that P19 cells can undergo cardiomyogenesis after treatment with chemical inducers such as DMSO, cardiac TFs such as Mef2c, and various cytokines [56][57][58][59][60]. It has been shown that Bmp treatment can promote cardiomyocyte differentiation in P19 cells by regulating Nkx2.5 activity [60]. To study Hand1 expression induced by Bmp2 and Bmp4 during cardiomyogenesis, we treated P19 cells with different concentrations of Bmp2 and Bmp4 for 6 days. Our western blot data indicated that both Bmp2 and Bmp4 induced Hand1 protein expression in a dose-dependent manner (Figure 4A,B). The qRT-PCR analysis also indicated that Hand1 expression was elevated in P19 cells after 6 days of Bmp2 and Bmp4 treatment (Figure 4C). Transcription factor Id1 is a known direct target of the canonical Bmp/Smad signaling pathway [61][62][63]. Bmp2/4 stimulation also induced Id1 gene expression, demonstrating that Bmp2 and Bmp4 activate the canonical Bmp/Smad signaling pathway (Figure 4D). Furthermore, we detected an elevated expression of cardiac TFs Nkx2.5 and Gata4 with Bmp treatment, indicating undergoing cardiomyogenesis in P19 cells (Figure 4E,F). Taken together, these data showed that the canonical Bmp/Smad signaling pathway induced Hand1 expression during cardiomyogenesis in P19 cells.
Ijms 22 09835 g004 550
Figure 4. Bmp2 and Bmp4 induce Hand1 expression in P19 cells. (A,B) P19 cells were stimulated with Bmp2 and 4 for 6 days. Levels of Hand1 were analyzed by western blotting. (C–F) Total RNA was harvested on day 6 with Bmp treatment for 6 days (100 ng/mL). qRT-PCR was performed for the analysis of Hand1, Id1, Nkx2.5, and Gata4 mRNA. Data are presented as means ± s.e.m. * indicates p-value < 0.05, *** indicates p-value < 0.001.

3. Discussion

In this study, we demonstrated that Hand1 is a direct downstream target of the canonical Bmp/Smad signaling pathway during heart development. Studies have indicated the importance of Hand1 and Hand2 during cardiac morphogenesis, including their contribution in NCCs, myocardium, endocardium, and epicardium. Hand1 and Hand2 display different restricted expression patterns in the developing heart. In mice, Hand1 is highly enriched in the OFT, the cardiomyocytes of the LV, and in the myocardial cuff, between E9.5–13.5 [64]. In contrast, Hand2 is expressed throughout the linear heart tube, including the RV, the atria, and the left ventricular chambers [65]. Here, we found that the Hand1 expression level is tightly regulated by Bmp signaling in a dose-dependent manner in the OFT, whereas the Hand2 expression level is not obviously affected by Bmp signaling activity changes. The Bmp2−/−; Bmp4+/− and Bmp2+/−; Bmp4−/− compound mutant embryos had low levels of Hand1 expression in the OFT, which indicated a functional redundancy between Bmp2 and Bmp4. The fully abolished Hand1 expression in the OFT of the Bmp2/4 dCKO mutant heart indicated that Bmp deletion in the SHF not only regulated Hand1 expression in the SHF-derived cells, but also Hand1 expression in neural crest-derived cells, suggesting that Bmp signaling functions in both cell-autonomous and non-cell-autonomous ways. Indeed, Bmp receptors also play essential roles during heart development, such as the Bmp receptor ALK3, that when specifically knocked-out in cardiac myocytes, resulted in cardiac septation and atrioventricular cushion morphogenesis [66]. However, the potential signaling cross talk between SHF progenitors and NCCs in the OFT, mediated by Bmp receptors, will need further investigation. In contrast to Bmp loss-of-function, Bmp gain-of-function leads to a robust increase in Hand1 expression, indicating that Bmp signaling is both necessary and sufficient to activate Hand1 transcription, further supporting the idea that Hand1 expression sensitively responds to Bmp signaling dosage.
In a facial skeletal development study, Claudio et al. reported that Bmp4 balances self-renewal and differentiation signals in cranial NCCs, and found that compared to the controls, Hand1 expression was expanded in the developing mandibles of mice with Bmp4 overexpression in NCCs at E11.5 [36]. In addition, Vincentz et al. found that during mandibular development, Bmp signaling and Hand2 synergistically activate Hand1 expression, whereas this regulation is inhibited by the homeodomain proteins distal-less homeobox 5 (Dlx5) and Dlx6. However, the Bmp/Hand2 co-regulation and Dlx5/6 antagonism regulation on Hand1 only occurred in cranial NCCs, not in cardiac NCCs [67]. Here, we found that Bmp signaling in the SHF likely regulates Hand1 expression in both SHF progenitors and cardiac NCCs during OFT development. However, Hand2 in the SHF likely does not participate in this regulation given that Hand2 expression was not altered upon Bmp deletion in the SHF.
To further understand the mechanism underlying sensitive expression responses of Hand1 to Bmp dosages, we analyzed the 5′UTR of Hand1 and identified conserved Bmp/Smad regulatory elements in the Hand1 5′UTR. We made the Hand1 5′UTR luciferase reporters and performed a luciferase assay. We found that both the Bmp treatment and overexpression of the constitutively active Bmp receptor (caALK3) induced Hand1 luciferase activity. To further consolidate this result, we also used inhibitory Smad6 and Smad1 shRNA to specifically block the Bmp/Smad signaling. We found Hand1 luciferase reporter activity was decreased when co-transfected with Smad6 and Smad1 shRNA. Notably, our ChIP assays’ data showed that Smad1/5/8 binds directly to Hand1 5′UTRs in the E9.5 wild-type mouse hearts. These data together indicated that the Bmp regulation on Hand1 functions through the Smads-mediated canonical Bmp signaling pathway.
Both in vivo and in vitro studies of cardiac cardiomyocyte differentiation systems give strong evidence that Bmps can specifically regulate cardiac differentiation and cardiomyogenesis [59][60][68][69][70]. Our previous work reported that Bmp signaling enhances myocardial differentiation during OFT development [17]. During embryogenesis, Hand1 is important for the morphogenic patterning and maturation of cardiomyocytes [20][27][29]. The conditional deletion of Hand1 in cardiomyocytes, using Nkx2.5Cre or a-myosin heavy chain Cre (aMHCCre) driver, results in multiple morphological anomalies that include cardiac conduction system defects, survivable interventricular septal defects, and abnormal LV papillary muscles [29]. Monzen et al. reported that Bmps induce P19 cells for cardiomyocyte differentiation through the mitogen-activated protein kinase kinase kinase TAK1 and cardiac TFs Csx/Nkx-2.5 and GATA-4 [59]. In our in vitro experiments examining Hand1 expression in P19 cells with treatments of varying Bmp2 and 4 concentrations, we found that both Bmp2 and 4 promote Hand1 expression in a dose-dependent manner. In addition, after Bmp2 and 4 treatment, cardiac TFs Nkx2.5 and Gata4 were also induced when Hand1 expression was increased. These data, together with previously published findings, suggest that Bmps could potentially activate Hand1 to promote cardiomyocyte differentiation. However, further electro-physiological experiments in P19 cells and in vivo investigations are still needed in the future.
In conclusion, to our knowledge, this study is the first to demonstrate that the canonical Bmp/Smad signaling pathway in the SHF directly activates Hand1 expression in a dose-dependent manner during OFT development. Our findings also revealed a potential cell-autonomous and non-cell-autonomous function of Bmp signaling in the SHF and provided better insights into the molecular regulation of OFT development.

4. Materials and Methods

4.1. Mouse Alleles and Transgenic Lines

The Bmp2 and Bmp4 conditional null, Bmp4tetO gain-of-function allele and the Mef2ccre line were previously described [17][36].

4.2. Antibodies and Reagents

Antibodies used in this study include P-Smad1/5/8 (Cell Signaling Technology, #13820, Danvers, MA, USA), Smad1 (Upstate Biotechnology, Lake Placid, NY, USA), Hand1 (R&D systems, AF3168-SP, Minneapolis, MN, USA), and GAPDH antibody (Abcam, #ab9485, Cambridge, UK). Bmp2 (R&D, #355BM, Minneapolis, MN, USA) and Bmp4 (R&D, #314BP, Minneapolis, MN, USA) proteins were purchased from R&D systems.

4.3. Whole-Mount In Situ Hybridization

Whole-mount and section in situ hybridization was performed as previously described [17]. The plasmids for Hand1 and Hand2 in situ probes were previously described [71]. For all the experiments, at least three controls and mutant embryos were analyzed for each probe.

4.4. Quantitative Real Time RT-PCR

Total RNA from embryonic hearts was isolated using the RNeasy Micro Kit (QIAGEN) [17]. Total RNA from P19 cells was extracted using TRIzol reagent (Life technologies, Carlsbad, CA, USA) following the manufacturer’s protocol. For qRT-PCR assays, iScript Reverse Transcription Supermix (Bio-Rad, Hercules, CA, USA) was used for RT-PCR, and SYBR Green PCR Master Mix (Applied Biosystems, Waltham, MA, USA) was used for real-time thermal cycling (Applied Biosystems, Waltham, MA, USA). All error bars represent SEM. Primers used for qRT-PCR were Gapdh forward, 5′-TGGCAAAGTGGAGATTGTTGCC-3′. Gapdh reverse, 5′-AAGATGGTGATGGGCTTCCCG-3′. Hand1 forward, 5′-GCCTACTTGATGGACGTGCT-3′. Hand1 reverse, 5′-CAACTCCCTTTTCCGCTTGC-3′. Gata4 forward, 5′-CCCTGGAAGACACCCCAATC-3′. Gata4 reverse, 5′-TTTGAATCCCCTCCTTCCGC-3′. Nkx2.5 forward, 5′-TGCTCTCCTGCTTTCCCAGCC-3′. Nkx2.5 reverse, 5′-CTTTGTCCAGCTCCACTGCCTT-3′. Id1 forward, 5′-TTGGTCTGTCGGAGCAAAGCGT-3′. Id1 reverse, 5′-CGTGAGTAGCAGCCGTTCATGT-3′.

4.5. Chromatin Immunoprecipitation

E9.5 wild-type mice embryonic hearts were dissected and followed by chromatin immunoprecipitation (ChIP) analysis, which was performed using a ChIP assay kit (Upstate) [17]. The two primers for amplifying the Bmp/Smad regulatory element in the 5′ upstream of the Hand1 genomic sequence were sense, 5′-AACCCGCAGGGCACAAGAA-3′, and antisense, 5′-TGGTTGTGCAAGAGATTGTGA-3′. The PCR product was evaluated for appropriate size on a 2% agarose gel and was confirmed by sequencing. As negative controls, no antibody was used; in addition, normal rabbit immunoglobulin G was used as a replacement for the anti-Smad1/5/8 (sc-6031-R, Santa Cruz) to reveal nonspecific immunoprecipitation of the chromatin.

4.6. Luciferase Reporter Assays

Expression and reporter plasmids were described above. Constitutively active ALK3 (caALK3), pcDNA3.1-Smad6 expression plasmid, and pSR siSmad1 plasmid were previously described [17]. To generate the Hand1 luciferase reporter plasmid, 2314bp 5′upstream of Hand1 genomic sequence was amplified using a high-fidelity PCR system (Roche) with two oligonucleotides, sense, 5′-ACGCGTAGGGTACAAAGGGAAACTGGGTGT-3′ (underlined letters indicate the MluI restriction site introduced for subcloning), and antisense, 5′-CTCGAGTGCTCACTCCCTGTACTGAACCTA-3′ (underlined letters indicate the XhoI restriction site introduced for subcloning), and subcloned into pGL3-Basic vector (Promega). P19 cells were transfected using Lipofectamine 3000 (Invitrogen). Luciferase activity assays were performed using the Luciferase Assay System (Promega).

4.7. Western Blotting

Western blot was performed as previously described using standard techniques [72]. After 6 days with or without Bmp2/4 treatment, P19 cells were harvested and lysated using 0.5% NP-40 lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5% NP-40, 10% glycerol, phosphatase and protease inhibitors) for 10 min on ice, and centrifuged at 14,000 rpm for 10 min at 4 °C. For Western blot analysis, the proteins were loaded and separated by SDS-PAGE, and transferred onto a PVDF membrane (Millipore, IPVH00010). The membranes were blocked in 5% non-fat milk for 1 h at room temperature and incubated with primary antibodies overnight at 4 °C. The membranes were incubated with HRP-conjugated secondary antibodies for 2 h at room temperature and were imaged by Bio-rad imaging systems. Antibodies used for immunoblotting are mentioned above.

4.8. Cell Culture

Mouse embryonic carcinoma cell line P19 were maintained in Minimum Essential Medium (MEM) supplemented with 10% fetal bovine serum (FBS) at 37 °C in a humidified incubator with 5% CO2. P19 cells were seeded at a concentration of 0.5 × 106 cells per well in 6-well plates and cultured for 24 h to reach 100% confluence (day 0). To induce differentiation, cells were washed in PBS and cultured in MEM supplemented with 10% fetal bovine serum (FBS), Bmp2 or Bmp4, referred to as differentiation medium.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/ijms22189835/s1, Figure S1: Hand2 is not changed in control and Bmp2/4 mutant; Figure S2: Diagram of the Bmp/Smad regulatory element in the 5′ upstream of Hand1 genomic sequence (at upper) and its phylogenetic sequence alignment (at lower).

This entry is adapted from the peer-reviewed paper 10.3390/ijms22189835

References

  1. Warnes, C.A.; Liberthson, R.; Danielson, G.K.; Dore, A.; Harris, L.; Hoffman, J.I.; Somerville, J.; Williams, R.G.; Webb, G.D. Task force 1: The changing profile of congenital heart disease in adult life. J. Am. Coll. Cardiol. 2001, 37, 1170–1175.
  2. High, F.A.; Jain, R.; Stoller, J.Z.; Antonucci, N.B.; Lu, M.M.; Loomes, K.M.; Kaestner, K.H.; Pear, W.S.; Epstein, J.A. Murine Jagged1/Notch signaling in the second heart field orchestrates Fgf8 expression and tissue-tissue interactions during outflow tract development. J. Clin. Investig. 2009, 119, 1986–1996.
  3. Erhardt, S.; Zheng, M.J.; Zhao, X.L.; Le, T.P.; Findley, T.O.; Wang, J. The Cardiac Neural Crest Cells in Heart Development and Congenital Heart Defects. J. Cardiovasc. Dev. Dis. 2021, 8, 89.
  4. Urist, M.R. Bone: Formation by autoinduction. Science 1965, 150, 893–899.
  5. Feng, X.H.; Derynck, R. Specificity and versatility in tgf-beta signaling through Smads. Annu. Rev. Cell Dev. Biol. 2005, 21, 659–693.
  6. ten Dijke, P.; Hill, C.S. New insights into TGF-beta-Smad signalling. Trends Biochem. Sci. 2004, 29, 265–273.
  7. Derynck, R.; Zhang, Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003, 425, 577–584.
  8. Bai, Y.; Wang, J.; Morikawa, Y.; Bonilla-Claudio, M.; Klysik, E.; Martin, J.F. Bmp signaling represses Vegfa to promote outflow tract cushion development. Development 2013, 140, 3395–3402.
  9. Wang, J.; Greene, S.B.; Martin, J.F. BMP signaling in congenital heart disease: New developments and future directions. Birth Defects Res. Part A Clin. Mol. Teratol. 2011, 91, 441–448.
  10. Liu, W.; Selever, J.; Wang, D.; Lu, M.F.; Moses, K.A.; Schwartz, R.J.; Martin, J.F. Bmp4 signaling is required for outflow-tract septation and branchial-arch artery remodeling. Proc. Natl. Acad. Sci. USA 2004, 101, 4489–4494.
  11. Prall, O.W.; Menon, M.K.; Solloway, M.J.; Watanabe, Y.; Zaffran, S.; Bajolle, F.; Biben, C.; McBride, J.J.; Robertson, B.R.; Chaulet, H.; et al. An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation. Cell 2007, 128, 947–959.
  12. Ma, L.; Lu, M.F.; Schwartz, R.J.; Martin, J.F. Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development 2005, 132, 5601–5611.
  13. Zhang, H.; Bradley, A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 1996, 122, 2977–2986.
  14. Rivera-Feliciano, J.; Tabin, C.J. Bmp2 instructs cardiac progenitors to form the heart-valve-inducing field. Dev. Biol. 2006, 295, 580–588.
  15. Jiao, K.; Kulessa, H.; Tompkins, K.; Zhou, Y.; Batts, L.; Baldwin, H.S.; Hogan, B.L. An essential role of Bmp4 in the atrioventricular septation of the mouse heart. Genes Dev. 2003, 17, 2362–2367.
  16. Chen, H.; Shi, S.; Acosta, L.; Li, W.; Lu, J.; Bao, S.; Chen, Z.; Yang, Z.; Schneider, M.D.; Chien, K.R.; et al. BMP10 is essential for maintaining cardiac growth during murine cardiogenesis. Development 2004, 131, 2219–2231.
  17. Wang, J.; Greene, S.B.; Bonilla-Claudio, M.; Tao, Y.; Zhang, J.; Bai, Y.; Huang, Z.; Black, B.L.; Wang, F.; Martin, J.F. Bmp signaling regulates myocardial differentiation from cardiac progenitors through a MicroRNA-mediated mechanism. Dev. Cell 2010, 19, 903–912.
  18. Hollenberg, S.M.; Sternglanz, R.; Cheng, P.F.; Weintraub, H. Identification of a new family of tissue-specific basic helix-loop-helix proteins with a two-hybrid system. Mol. Cell. Biol. 1995, 15, 3813–3822.
  19. Scott, I.C.; Anson-Cartwright, L.; Riley, P.; Reda, D.; Cross, J.C. The HAND1 basic helix-loop-helix transcription factor regulates trophoblast differentiation via multiple mechanisms. Mol. Cell. Biol. 2000, 20, 530–541.
  20. Firulli, A.B.; McFadden, D.G.; Lin, Q.; Srivastava, D.; Olson, E.N. Heart and extra-embryonic mesodermal defects in mouse embryos lacking the bHLH transcription factor Hand1. Nat. Genet. 1998, 18, 266–270.
  21. Srivastava, D.; Cserjesi, P.; Olson, E.N. A subclass of bHLH proteins required for cardiac morphogenesis. Science 1995, 270, 1995–1999.
  22. Srivastava, D.; Thomas, T.; Lin, Q.; Kirby, M.L.; Brown, D.; Olson, E.N. Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nat. Genet. 1997, 16, 154–160.
  23. Cserjesi, P.; Brown, D.; Lyons, G.E.; Olson, E.N. Expression of the novel basic helix-loop-helix gene eHAND in neural crest derivatives and extraembryonic membranes during mouse development. Dev. Biol. 1995, 170, 664–678.
  24. Vincentz, J.W.; Toolan, K.P.; Zhang, W.; Firulli, A.B. Hand factor ablation causes defective left ventricular chamber development and compromised adult cardiac function. PLoS Genet. 2017, 13, e1006922.
  25. Smart, N.; Dube, K.N.; Riley, P.R. Identification of Thymosin beta4 as an effector of Hand1-mediated vascular development. Nat. Commun. 2010, 1, 46.
  26. Firulli, A.B. A HANDful of questions: The molecular biology of the heart and neural crest derivatives (HAND)-subclass of basic helix-loop-helix transcription factors. Gene 2003, 312, 27–40.
  27. Riley, P.; Anson-Cartwright, L.; Cross, J.C. The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis. Nat. Genet. 1998, 18, 271–275.
  28. Risebro, C.A.; Smart, N.; Dupays, L.; Breckenridge, R.; Mohun, T.J.; Riley, P.R. Hand1 regulates cardiomyocyte proliferation versus differentiation in the developing heart. Development 2006, 133, 4595–4606.
  29. Firulli, B.A.; George, R.M.; Harkin, J.; Toolan, K.P.; Gao, H.; Liu, Y.; Zhang, W.; Field, L.J.; Liu, Y.; Shou, W.; et al. HAND1 loss-of-function within the embryonic myocardium reveals survivable congenital cardiac defects and adult heart failure. Cardiovasc. Res. 2020, 116, 605–618.
  30. Reamon-Buettner, S.M.; Ciribilli, Y.; Traverso, I.; Kuhls, B.; Inga, A.; Borlak, J. A functional genetic study identifies HAND1 mutations in septation defects of the human heart. Hum. Mol. Genet. 2009, 18, 3567–3578.
  31. Zhou, Y.M.; Dai, X.Y.; Qiu, X.B.; Yuan, F.; Li, R.G.; Xu, Y.J.; Qu, X.K.; Huang, R.T.; Xue, S.; Yang, Y.Q. HAND1 loss-of-function mutation associated with familial dilated cardiomyopathy. Clin. Chem. Lab. Med. 2016, 54, 1161–1167.
  32. Yamagishi, H.; Olson, E.N.; Srivastava, D. The basic helix-loop-helix transcription factor, dHAND, is required for vascular development. J. Clin. Investig. 2000, 105, 261–270.
  33. Sun, Y.M.; Wang, J.; Qiu, X.B.; Yuan, F.; Li, R.G.; Xu, Y.J.; Qu, X.K.; Shi, H.Y.; Hou, X.M.; Huang, R.T.; et al. A HAND2 Loss-of-Function Mutation Causes Familial Ventricular Septal Defect and Pulmonary Stenosis. G3 2016, 6, 987–992.
  34. Buckingham, M.; Meilhac, S.; Zaffran, S. Building the mammalian heart from two sources of myocardial cells. Nat. Rev. Genet. 2005, 6, 826–835.
  35. Brade, T.; Pane, L.S.; Moretti, A.; Chien, K.R.; Laugwitz, K.L. Embryonic heart progenitors and cardiogenesis. Cold Spring Harb. Perspect. Med. 2013, 3, a013847.
  36. Bonilla-Claudio, M.; Wang, J.; Bai, Y.; Klysik, E.; Selever, J.; Martin, J.F. Bmp signaling regulates a dose-dependent transcriptional program to control facial skeletal development. Development 2012, 139, 709–719.
  37. Macias, M.J.; Martin-Malpartida, P.; Massague, J. Structural determinants of Smad function in TGF-beta signaling. Trends Biochem. Sci. 2015, 40, 296–308.
  38. Martin-Malpartida, P.; Batet, M.; Kaczmarska, Z.; Freier, R.; Gomes, T.; Aragon, E.; Zou, Y.; Wang, Q.; Xi, Q.; Ruiz, L.; et al. Structural basis for genome wide recognition of 5-bp GC motifs by SMAD transcription factors. Nat. Commun. 2017, 8, 2070.
  39. Derynck, R.; Zhang, Y.; Feng, X.H. Smads: Transcriptional activators of TGF-beta responses. Cell 1998, 95, 737–740.
  40. Massague, J.; Seoane, J.; Wotton, D. Smad transcription factors. Genes Dev. 2005, 19, 2783–2810.
  41. Morikawa, M.; Koinuma, D.; Miyazono, K.; Heldin, C.H. Genome-wide mechanisms of Smad binding. Oncogene 2013, 32, 1609–1615.
  42. Shi, Y.; Massague, J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113, 685–700.
  43. Morikawa, M.; Koinuma, D.; Tsutsumi, S.; Vasilaki, E.; Kanki, Y.; Heldin, C.H.; Aburatani, H.; Miyazono, K. ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif. Nucleic Acids Res. 2011, 39, 8712–8727.
  44. Kim, J.; Johnson, K.; Chen, H.J.; Carroll, S.; Laughon, A. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 1997, 388, 304–308.
  45. BabuRajendran, N.; Palasingam, P.; Narasimhan, K.; Sun, W.; Prabhakar, S.; Jauch, R.; Kolatkar, P.R. Structure of Smad1 MH1/DNA complex reveals distinctive rearrangements of BMP and TGF-beta effectors. Nucleic Acids Res. 2010, 38, 3477–3488.
  46. Chai, N.; Li, W.X.; Wang, J.; Wang, Z.X.; Yang, S.M.; Wu, J.W. Structural basis for the Smad5 MH1 domain to recognize different DNA sequences. Nucleic Acids Res. 2017, 45, 6255–6257.
  47. Fujii, M.; Takeda, K.; Imamura, T.; Aoki, H.; Sampath, T.K.; Enomoto, S.; Kawabata, M.; Kato, M.; Ichijo, H.; Miyazono, K. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol. Biol. Cell 1999, 10, 3801–3813.
  48. Hata, A.; Lagna, G.; Massague, J.; Hemmati-Brivanlou, A. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev. 1998, 12, 186–197.
  49. Callis, T.E.; Cao, D.; Wang, D.Z. Bone morphogenetic protein signaling modulates myocardin transactivation of cardiac genes. Circ. Res. 2005, 97, 992–1000.
  50. Brown, C.O., 3rd; Chi, X.; Garcia-Gras, E.; Shirai, M.; Feng, X.H.; Schwartz, R.J. The cardiac determination factor, Nkx2-5, is activated by mutual cofactors GATA-4 and Smad1/4 via a novel upstream enhancer. J. Biol. Chem. 2004, 279, 10659–10669.
  51. Shi, Y.; Katsev, S.; Cai, C.; Evans, S. BMP signaling is required for heart formation in vertebrates. Dev. Biol. 2000, 224, 226–237.
  52. McBurney, M.W.; Jones-Villeneuve, E.M.; Edwards, M.K.; Anderson, P.J. Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line. Nature 1982, 299, 165–167.
  53. McBurney, M.W. P19 embryonal carcinoma cells. Int. J. Dev. Biol. 1993, 37, 135–140.
  54. Wilton, S.; Skerjanc, I. Factors in serum regulate muscle development in P19 cells. In Vitro Cell. Dev. Biol. Anim. 1999, 35, 175–177.
  55. Skerjanc, I.S. Cardiac and skeletal muscle development in P19 embryonal carcinoma cells. Trends Cardiovasc. Med. 1999, 9, 139–143.
  56. Grepin, C.; Robitaille, L.; Antakly, T.; Nemer, M. Inhibition of transcription factor GATA-4 expression blocks in vitro cardiac muscle differentiation. Mol. Cell. Biol. 1995, 15, 4095–4102.
  57. Jamali, M.; Rogerson, P.J.; Wilton, S.; Skerjanc, I.S. Nkx2-5 activity is essential for cardiomyogenesis. J. Biol. Chem. 2001, 276, 42252–42258.
  58. Skerjanc, I.S.; Petropoulos, H.; Ridgeway, A.G.; Wilton, S. Myocyte enhancer factor 2C and Nkx2-5 up-regulate each other's expression and initiate cardiomyogenesis in P19 cells. J. Biol. Chem. 1998, 273, 34904–34910.
  59. Monzen, K.; Shiojima, I.; Hiroi, Y.; Kudoh, S.; Oka, T.; Takimoto, E.; Hayashi, D.; Hosoda, T.; Habara-Ohkubo, A.; Nakaoka, T.; et al. Bone morphogenetic proteins induce cardiomyocyte differentiation through the mitogen-activated protein kinase kinase kinase TAK1 and cardiac transcription factors Csx/Nkx-2.5 and GATA-4. Mol. Cell. Biol. 1999, 19, 7096–7105.
  60. Jamali, M.; Karamboulas, C.; Rogerson, P.J.; Skerjanc, I.S. BMP signaling regulates Nkx2-5 activity during cardiomyogenesis. FEBS Lett. 2001, 509, 126–130.
  61. Benezra, R.; Davis, R.L.; Lockshon, D.; Turner, D.L.; Weintraub, H. The protein Id: A negative regulator of helix-loop-helix DNA binding proteins. Cell 1990, 61, 49–59.
  62. Norton, J.D.; Deed, R.W.; Craggs, G.; Sablitzky, F. Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol. 1998, 8, 58–65.
  63. Hollnagel, A.; Oehlmann, V.; Heymer, J.; Ruther, U.; Nordheim, A. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J. Biol. Chem. 1999, 274, 19838–19845.
  64. Firulli, B.A.; McConville, D.P.; Byers, J.S., 3rd; Vincentz, J.W.; Barnes, R.M.; Firulli, A.B. Analysis of a Hand1 hypomorphic allele reveals a critical threshold for embryonic viability. Dev. Dyn. 2010, 239, 2748–2760.
  65. Thomas, T.; Yamagishi, H.; Overbeek, P.A.; Olson, E.N.; Srivastava, D. The bHLH factors, dHAND and eHAND, specify pulmonary and systemic cardiac ventricles independent of left-right sidedness. Dev. Biol. 1998, 196, 228–236.
  66. Gaussin, V.; Van de Putte, T.; Mishina, Y.; Hanks, M.C.; Zwijsen, A.; Huylebroeck, D.; Behringer, R.R.; Schneider, M.D. Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3. Proc. Natl. Acad. Sci. USA 2002, 99, 2878–2883.
  67. Vincentz, J.W.; Casasnovas, J.J.; Barnes, R.M.; Que, J.; Clouthier, D.E.; Wang, J.; Firulli, A.B. Exclusion of Dlx5/6 expression from the distal-most mandibular arches enables BMP-mediated specification of the distal cap. Proc. Natl. Acad. Sci. USA 2016, 113, 7563–7568.
  68. Winnier, G.; Blessing, M.; Labosky, P.A.; Hogan, B.L. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 1995, 9, 2105–2116.
  69. Schultheiss, T.M.; Burch, J.B.; Lassar, A.B. A role for bone morphogenetic proteins in the induction of cardiac myogenesis. Genes Dev. 1997, 11, 451–462.
  70. Yuasa, S.; Itabashi, Y.; Koshimizu, U.; Tanaka, T.; Sugimura, K.; Kinoshita, M.; Hattori, F.; Fukami, S.; Shimazaki, T.; Ogawa, S.; et al. Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat. Biotechnol. 2005, 23, 607–611.
  71. McFadden, D.G.; Barbosa, A.C.; Richardson, J.A.; Schneider, M.D.; Srivastava, D.; Olson, E.N. The Hand1 and Hand2 transcription factors regulate expansion of the embryonic cardiac ventricles in a gene dosage-dependent manner. Development 2005, 132, 189–201.
  72. Wang, J.; Klysik, E.; Sood, S.; Johnson, R.L.; Wehrens, X.H.; Martin, J.F. Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification. Proc. Natl. Acad. Sci. USA 2010, 107, 9753–9758.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
This entry is offline, you can click here to edit this entry!
ScholarVision Creations
Feedback